Experts express concern over pharmaceutical giant Eli Lilly's new website connecting patients to obesity drugs
Eli Lilly, which makes obesity and diabetes drugs like Zepbound and Mounjaro, has launched a new website that connects patients to telehealth services, but the service worries some health experts.
Colorado poised to ban 'fatphobia' in workplace, housing
Lawmakers in Colorado are expected to pass legislation that bans bias based on “fatphobia" to prevent employers and landlords from discriminating against those who are overweight.
FDA approves Eli Lilly's tirzepatide for weight loss
Eli Lilly's drug tirzepatide was approved by the Food and Drug Administration to help people who are overweight and have a weight-related medical condition lose weight.
Eli Lilly, Novo Nordisk test popular weight loss-related drugs on children
Eli Lilly and Novo Nordisk are seeking to test some of their most popular drugs approved for Type 2 diabetes and weight management in adults on children.
Novo Nordisk shares fall after media report on quality lapses at US plant
Novo Nordisk, a pharmaceutical company, experienced a decline in its stock prices following a report by financial news agency MarketWire.
Pfizer's diabetes pill shows similar weight loss results as Ozempic
Pfizer's oral diabetes drug could join the lineup of sought-after drugs tackling weight loss. A recent study showed promising weight loss results in those with Type 2 diabetes.





